DCF — HARBORVIEW MEDICAL CENTER
Enterprise Value: $-2.1B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-2.1B
Enterprise Value
$-668.8M
PV of Cash Flows
$-1.5B
PV of Terminal Value
$-2.3B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.2B | $-134.0M | -11.0% | $-186.4M | $-169.4M |
| Year 2 | $1.3B | $-125.3M | -10.0% | $-179.2M | $-148.1M |
| Year 3 | $1.3B | $-115.9M | -9.0% | $-171.5M | $-128.8M |
| Year 4 | $1.4B | $-112.6M | -8.0% | $-169.8M | $-116.0M |
| Year 5 | $1.4B | $-112.5M | -8.0% | $-171.5M | $-106.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-2.1B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.2B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11325723464204866
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5